HOME >> BIOLOGY >> NEWS
The Cancer Genome Atlas awards funds for technology development

As part of The Cancer Genome Atlas (TCGA) pilot project, the National Institutes of Health (NIH) today awarded eight two-year grants totaling $3.4 million to support the development of innovative technologies for exploring the genomic underpinnings of cancer.

The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both part of NIH, announced the TCGA pilot in December 2005 to test the feasibility of a large-scale, systematic approach to identifying the changes that occur in the genomes of cancer cells. The goal is to generate genomic information that the research community can use to develop new and improved strategies for detecting, treating and, ultimately, preventing cancer.

The types of tumors being studied in the pilot include brain cancer (glioblastoma), ovarian cancer and lung cancer (squamous cell), which together account for more than 200,000 cases of cancer in the United States each year.

In addition to the detailed genomic data it will generate, there is great hope that TCGA will both advance technological development and drive down its cost, said NCI Director John E. Niederhuber, M.D. Our greatest challenge will be in applying the volumes of information TCGA will provide about tumors to the genomic data NCI is gathering from large cohorts of patients, in order to better predict, and even prevent, the earliest development of cancer.

Cancer poses a very complex challenge. Each of the dozens of types of cancer likely will have a different genomic profile or set of profiles. We urgently need tools equal to this task, said NHGRI Director Francis S. Collins, M.D., Ph.D., whose institute led the NIH component of the Human Genome Project. One of the major lessons we learned from the Human Genome Project is that technology development is essential for success.

The institutions and principal investigators chosen to receive the two-year grants are:

  • Baylor
    '"/>


Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
2-Jul-2007


Page: 1 2 3

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
4. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
5. Cancer stem cells can go it alone
6. Cancer drug enhances long-term memory
7. Cancer cells reprogram energy needs to grow and spread, study suggests
8. Cancer scientists create human leukemia process to map how disease begins, progresses
9. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
10. Other highlights from the April 18 Journal of the National Cancer Institute
11. American Association for Cancer Research provides support for promising cancer scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
(Date:10/10/2017)... ... 2017 , ... The Pittcon Program Committee is pleased to ... who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each award ... conference and exposition for laboratory science, which will be held February 26-March 1, ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology:
Cached News: